Clinical Trials Directory

Trials / Completed

CompletedNCT03769818

Role of Dexamethasone for Erector Spinae Plane Block in Patients Undergoing Total Abdominal Hysterectomy

Role of Adjuvant Dexamethasone for Erector Spinae Plane Block for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy: A Randomized, Double-blind Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Aswan University Hospital · Academic / Other
Sex
Female
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The aim to study the efficacy of bupivacaine 0.25% with dexamethasone and that of bupivacaine 0.25% alone for erector spinae plane block for postoperative analgesia in patients undergoing total abdominal hysterectomy Group 1: bupivacaine 0.25% + dexamethasone 8 mg * Group 2: bupivacaine 0.25% * Group3: control group A prospective Randomized Interventional double-blind study.

Detailed description

Optimal dynamic analgesia is recognized as the key to enhanced recovery following open abdominal surgery. In the last decade, there has been a significant shift away from thoracic epidural analgesia (TEA) that has been long considered as the gold standard. Various techniques have tried to replicate the analgesic efficacy of TEA. They include transversus abdominis plane analgesia (TAP), rectus sheath analgesia (RS), wound infusion analgesia (WI) and trans muscular quadratus lumborum analgesia. However, each of these techniques has specific limitations that prevent them from being the analgesic technique of choice for all open abdominal surgeries. Chin et al first described the erector spinae plane (ESP) block for providing analgesia following ventral hernia repair. The unique feature of the ultrasound-guided truncal blocks is that in all of these techniques, in contrast to peripheral nerve blocks, no nerve or plexus needs to be identified: Local anesthesia (LA) is injected in a particular muscle plane, in which the injectate spreads and reaches the intended nerves. This simple mechanism has made delivery of nerve blocks easy and versatile.

Conditions

Interventions

TypeNameDescription
DRUGbupivacaineBilateral TAP block with 20 ml of 0.25% bupivacaine
DRUGdexamethasoneBilateral TAP block with 4 mg/kg dexamethasone diluted with isotonic saline.
DRUGplacebo to dexamethasoneBilateral TAP block with placebo to dexamethasone.
DRUGplacebo to bupivacaineBilateral TAP block with placebo to bupivacaine.

Timeline

Start date
2019-01-01
Primary completion
2020-03-30
Completion
2020-08-01
First posted
2018-12-10
Last updated
2020-08-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03769818. Inclusion in this directory is not an endorsement.